DK1864987T3 - Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater - Google Patents

Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Info

Publication number: DK1864987T3
Authority: DK; Denmark
Prior art keywords: protected; dieneol; carboxylates; preparing; methods
Prior art date: 2004-02-06

Application number

DK07014411.8T

Other languages

English (en)

Inventor

Andreas Stumpf

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-06

Filing date

2005-02-04

Publication date

2010-04-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34860329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1864987(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-02-04 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2010-04-12 Application granted granted Critical

2010-04-12 Publication of DK1864987T3 publication Critical patent/DK1864987T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)

DK07014411.8T 2004-02-06 2005-02-04 Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater DK1864987T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US54271104P	2004-02-06	2004-02-06

Publications (1)

Publication Number	Publication Date
DK1864987T3 true DK1864987T3 (da)	2010-04-12

Family

ID=34860329

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05712726T DK1711502T3 (da)	2004-02-06	2005-02-04	Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater
DK07014411.8T DK1864987T3 (da)	2004-02-06	2005-02-04	Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05712726T DK1711502T3 (da)	2004-02-06	2005-02-04	Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Country Status (34)

Country	Link
US (6)	US8003793B2 (da)
EP (3)	EP1864987B1 (da)
JP (1)	JP4963968B2 (da)
KR (4)	KR100921695B1 (da)
CN (1)	CN1918168B (da)
AP (1)	AP2006003716A0 (da)
AT (2)	ATE406372T1 (da)
AU (1)	AU2005212258B2 (da)
BR (1)	BRPI0506607B8 (da)
CA (2)	CA2555215C (da)
CR (1)	CR8590A (da)
CY (2)	CY1108506T1 (da)
DE (2)	DE602005009321D1 (da)
DK (2)	DK1711502T3 (da)
EA (2)	EA016062B1 (da)
EC (1)	ECSP066824A (da)
ES (2)	ES2338054T3 (da)
GE (1)	GEP20084454B (da)
HK (2)	HK1119160A1 (da)
HR (2)	HRP20080618T3 (da)
IL (2)	IL177281A (da)
MA (1)	MA28346A1 (da)
MX (1)	MXPA06008931A (da)
NO (2)	NO20063989L (da)
NZ (2)	NZ548786A (da)
PL (2)	PL1711502T3 (da)
PT (2)	PT1711502E (da)
RS (2)	RS50663B (da)
SG (1)	SG150500A1 (da)
SI (2)	SI1864987T1 (da)
TN (1)	TNSN06248A1 (da)
UA (2)	UA88646C2 (da)
WO (1)	WO2005077957A2 (da)
ZA (1)	ZA200606252B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA88646C2 (uk)	2004-02-06	2009-11-10	Евро-Селтик С.А.	Способи одержання 3-о-захищених морфінонів і 3-о-захищених морфінондієнолкарбоксилатів, а також композиція для окислення спирту до кетону
NZ575620A (en) *	2006-09-20	2010-11-26	Mallinckrodt Inc	Preparation of substituted morphinan-6-ones and salts and intermediates thereof
PL2137189T3 (pl) *	2007-03-06	2015-12-31	SpecGx LLC	Sposób wytwarzania czwartorzędowych N-alkilowych soli alkaloidu morfinanowego
US9040726B2 (en)	2007-03-06	2015-05-26	Mallinckrodt Llc	Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
US8148528B2 (en) *	2008-05-27	2012-04-03	Mallinckrodt Llc	Processes and compounds for the preparation of normorphinans
WO2010028004A2 (en)	2008-09-03	2010-03-11	Mallinckrodt Inc.	Substituted berbines and processes for their synthesis
SG184523A1 (en)	2010-05-10	2012-11-29	Euro Celtique Sa	Pharmaceutical compositions comprising hydromorphone and naloxone
KR101479388B1 (ko)	2010-05-10	2015-01-05	유로-셀티큐 에스.에이.	활성제 로딩된 과립과 추가의 활성제와의 조합물
PH12012502083A1 (en)	2010-05-10	2017-07-26	Euro Celtique Sa	Manufacturing of active-free granules and tablets comprising the same
AU2014350135B2 (en)	2013-11-13	2017-08-31	Euro-Celtique S.A.	Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
MX2018001968A (es)	2015-09-30	2018-11-09	Fujifilm Finechemicals Co Ltd	Metodo de produccion de compuestos organicos.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2654756A (en)	1949-10-20	1953-10-06	Mallinckrodt Chemical Works	Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
DE902257C (de)	1951-07-17	1954-01-21	Knoll Ag	Verfahren zur Herstellung von Acylderivaten der Enolform des Codeinons
GB1495271A (en) *	1974-04-10	1977-12-14	Macfarlan Smith Ltd	Dehydrohalogenation of codeinone derivatives
US4472253A (en) *	1981-08-17	1984-09-18	The Florida Board Of Regents On Behalf Of The Florida State University	Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative
US5112975A (en) *	1984-03-27	1992-05-12	Mallinckrodt Specialty Chemicals Company	Preparation of noroxymorphone from morphine
SE9003665D0 (sv) *	1990-11-16	1990-11-16	Kabivitrum Ab	Morphine prodrugs
GB9116909D0 (en) *	1991-08-06	1991-09-18	Salford Ultrafine Chem & Res	Morphine derivatives
US5821374A (en) *	1995-11-21	1998-10-13	Hoffmann-La Roche Inc.	Process for the oxidation of alcohols
US5869669A (en) *	1996-07-26	1999-02-09	Penick Corporation	Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) *	1997-06-30	1997-09-03	Johnson Matthey Plc	Preparation of opiates
US6177567B1 (en) *	1999-10-15	2001-01-23	Boehringer Ingelheim Chemicals, Inc.	Method for preparing oxycodone
US6596877B2 (en) *	2001-10-17	2003-07-22	Novartis Ag	Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
UA88646C2 (uk)	2004-02-06	2009-11-10	Евро-Селтик С.А.	Способи одержання 3-о-захищених морфінонів і 3-о-захищених морфінондієнолкарбоксилатів, а також композиція для окислення спирту до кетону

2005
- 2005-02-04 UA UAA200704105A patent/UA88646C2/uk unknown
- 2005-02-04 ES ES07014411T patent/ES2338054T3/es not_active Expired - Lifetime
- 2005-02-04 WO PCT/US2005/003390 patent/WO2005077957A2/en active Application Filing
- 2005-02-04 DK DK05712726T patent/DK1711502T3/da active
- 2005-02-04 CN CN2005800040830A patent/CN1918168B/zh not_active Expired - Lifetime
- 2005-02-04 AP AP2006003716A patent/AP2006003716A0/xx unknown
- 2005-02-04 RS RSP-2008/0553A patent/RS50663B/sr unknown
- 2005-02-04 SI SI200530925T patent/SI1864987T1/sl unknown
- 2005-02-04 GE GEAP20059608A patent/GEP20084454B/en unknown
- 2005-02-04 US US10/588,637 patent/US8003793B2/en active Active
- 2005-02-04 SI SI200530468T patent/SI1711502T1/sl unknown
- 2005-02-04 EA EA200801811A patent/EA016062B1/ru not_active IP Right Cessation
- 2005-02-04 KR KR1020077025206A patent/KR100921695B1/ko active IP Right Grant
- 2005-02-04 NZ NZ548786A patent/NZ548786A/en unknown
- 2005-02-04 SG SG200900838-4A patent/SG150500A1/en unknown
- 2005-02-04 BR BRPI0506607A patent/BRPI0506607B8/pt active IP Right Grant
- 2005-02-04 AU AU2005212258A patent/AU2005212258B2/en not_active Expired
- 2005-02-04 EP EP07014411A patent/EP1864987B1/en not_active Expired - Lifetime
- 2005-02-04 MX MXPA06008931A patent/MXPA06008931A/es active IP Right Grant
- 2005-02-04 AT AT05712726T patent/ATE406372T1/de active
- 2005-02-04 JP JP2006552236A patent/JP4963968B2/ja not_active Expired - Lifetime
- 2005-02-04 KR KR1020077025207A patent/KR20070108956A/ko not_active Application Discontinuation
- 2005-02-04 DE DE602005009321T patent/DE602005009321D1/de not_active Expired - Lifetime
- 2005-02-04 CA CA2555215A patent/CA2555215C/en not_active Expired - Lifetime
- 2005-02-04 DE DE602005018265T patent/DE602005018265D1/de not_active Expired - Lifetime
- 2005-02-04 RS RSP-2010/0064A patent/RS51317B/sr unknown
- 2005-02-04 PT PT05712726T patent/PT1711502E/pt unknown
- 2005-02-04 ES ES05712726T patent/ES2313299T3/es not_active Expired - Lifetime
- 2005-02-04 DK DK07014411.8T patent/DK1864987T3/da active
- 2005-02-04 PL PL05712726T patent/PL1711502T3/pl unknown
- 2005-02-04 PL PL07014411T patent/PL1864987T3/pl unknown
- 2005-02-04 EP EP05712726A patent/EP1711502B1/en not_active Expired - Lifetime
- 2005-02-04 EP EP09015220A patent/EP2194059A3/en not_active Withdrawn
- 2005-02-04 KR KR1020097016500A patent/KR101011460B1/ko active IP Right Grant
- 2005-02-04 PT PT07014411T patent/PT1864987E/pt unknown
- 2005-02-04 NZ NZ565355A patent/NZ565355A/en unknown
- 2005-02-04 EA EA200601394A patent/EA012905B1/ru not_active IP Right Cessation
- 2005-02-04 CA CA2808199A patent/CA2808199C/en not_active Expired - Lifetime
- 2005-02-04 AT AT07014411T patent/ATE451374T1/de active
- 2005-04-02 UA UAA200609622A patent/UA87833C2/uk unknown
2006
- 2006-07-28 ZA ZA200606252A patent/ZA200606252B/en unknown
- 2006-08-03 IL IL177281A patent/IL177281A/en active IP Right Grant
- 2006-08-04 TN TNP2006000248A patent/TNSN06248A1/fr unknown
- 2006-08-04 MA MA29240A patent/MA28346A1/fr unknown
- 2006-09-01 CR CR8590A patent/CR8590A/es unknown
- 2006-09-05 KR KR1020067018113A patent/KR100921696B1/ko active IP Right Grant
- 2006-09-05 EC EC2006006824A patent/ECSP066824A/es unknown
- 2006-09-06 NO NO20063989A patent/NO20063989L/no not_active Application Discontinuation
2007
- 2007-04-18 HK HK08106459.3A patent/HK1119160A1/xx not_active IP Right Cessation
- 2007-04-18 HK HK07104100.2A patent/HK1103071A1/xx not_active IP Right Cessation
2008
- 2008-11-12 CY CY20081101295T patent/CY1108506T1/el unknown
- 2008-11-26 HR HR20080618T patent/HRP20080618T3/xx unknown
2010
- 2010-02-25 CY CY20101100178T patent/CY1109838T1/el unknown
- 2010-03-05 HR HR20100123T patent/HRP20100123T1/hr unknown
- 2010-05-06 IL IL205596A patent/IL205596A/en active IP Right Grant
2011
- 2011-07-22 US US13/189,228 patent/US8198444B2/en not_active Expired - Lifetime
2012
- 2012-05-15 US US13/472,227 patent/US8685996B2/en not_active Expired - Lifetime
2014
- 2014-02-24 US US14/188,430 patent/US8975257B2/en not_active Expired - Lifetime
2015
- 2015-03-02 NO NO20150276A patent/NO339083B1/no unknown
- 2015-03-03 US US14/637,129 patent/US9670218B2/en not_active Expired - Fee Related
2017
- 2017-05-04 US US15/587,118 patent/US20170233400A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO20150276L (no)	2006-10-31
RS50663B (sr)	2010-06-30
CR8590A (es)	2007-07-19
NO20063989L (no)	2006-10-31
EP1864987A2 (en)	2007-12-12
US20120225902A1 (en)	2012-09-06
EP2194059A2 (en)	2010-06-09
IL177281A (en)	2012-02-29
EA200601394A1 (ru)	2006-12-29
CN1918168B (zh)	2011-04-27
KR20070108956A (ko)	2007-11-13
US20150239898A1 (en)	2015-08-27
EA016062B1 (ru)	2012-01-30
TNSN06248A1 (fr)	2007-12-03
US8685996B2 (en)	2014-04-01
IL177281A0 (en)	2006-12-10
BRPI0506607A (pt)	2007-05-02
JP2007520563A (ja)	2007-07-26
KR20070117701A (ko)	2007-12-12
EA012905B1 (ru)	2010-02-26
GEP20084454B (en)	2008-08-10
AP2006003716A0 (en)	2006-08-31
CA2808199A1 (en)	2005-08-25
EP1864987B1 (en)	2009-12-09
US8003793B2 (en)	2011-08-23
KR20070026401A (ko)	2007-03-08
SI1864987T1 (sl)	2010-04-30
MA28346A1 (fr)	2006-12-01
US20170233400A1 (en)	2017-08-17
US8975257B2 (en)	2015-03-10
CY1109838T1 (el)	2014-09-10
WO2005077957A3 (en)	2006-05-04
SG150500A1 (en)	2009-03-30
CY1108506T1 (el)	2014-04-09
ZA200606252B (en)	2007-11-28
NZ548786A (en)	2008-08-29
EP1864987A3 (en)	2008-02-20
PT1864987E (pt)	2010-03-09
ES2313299T3 (es)	2009-03-01
ES2338054T3 (es)	2010-05-03
MXPA06008931A (es)	2007-01-26
AU2005212258A1 (en)	2005-08-25
EP1711502A2 (en)	2006-10-18
HK1119160A1 (en)	2009-02-27
ATE406372T1 (de)	2008-09-15
KR100921695B1 (ko)	2009-10-15
DE602005018265D1 (de)	2010-01-21
RS51317B (sr)	2010-12-31
KR100921696B1 (ko)	2009-10-15
ATE451374T1 (de)	2009-12-15
BRPI0506607B8 (pt)	2021-05-25
KR101011460B1 (ko)	2011-01-28
US9670218B2 (en)	2017-06-06
US20140171643A1 (en)	2014-06-19
CA2808199C (en)	2015-10-27
CA2555215A1 (en)	2005-08-25
UA87833C2 (uk)	2009-08-25
NO339083B1 (no)	2016-11-14
ECSP066824A (es)	2006-12-29
SI1711502T1 (sl)	2009-02-28
CA2555215C (en)	2013-05-21
HRP20100123T1 (hr)	2010-04-30
WO2005077957A2 (en)	2005-08-25
KR20090089486A (ko)	2009-08-21
EP2194059A3 (en)	2010-09-22
AU2005212258B2 (en)	2008-05-22
HK1103071A1 (en)	2007-12-14
PT1711502E (pt)	2008-11-20
DK1711502T3 (da)	2008-12-01
US20120022259A1 (en)	2012-01-26
DE602005009321D1 (de)	2008-10-09
EP1711502B1 (en)	2008-08-27
PL1864987T3 (pl)	2010-05-31
US8198444B2 (en)	2012-06-12
HRP20080618T3 (en)	2009-01-31
EA200801811A1 (ru)	2008-12-30
PL1711502T3 (pl)	2009-02-27
BRPI0506607B1 (pt)	2018-01-16
UA88646C2 (uk)	2009-11-10
JP4963968B2 (ja)	2012-06-27
IL205596A (en)	2011-11-30
CN1918168A (zh)	2007-02-21
NZ565355A (en)	2008-09-26
US20080146804A1 (en)	2008-06-19

Publication	Publication Date	Title
DK1948852T3 (da)	2019-01-02	Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK2102398T3 (da)	2017-11-13	Fremgangsmåde til fremstilling af en ankelsok og ankelsok opnået derved
DK1896065T4 (da)	2014-10-20	Fremgangsmåde til fremstilling af vacciner
DK1852430T3 (da)	2019-08-05	Fremgangsmåde til fremstilling af proanthocyanidinoligomer
IS8204A (is)	2006-07-01	Tæki og aðferð til að hluta niður
DK2127419T3 (da)	2019-09-23	Fremgangsmåde og anordning til tilvejebringelse af effektiv diskontinuerlig kommunikation
DK1924514T3 (da)	2010-07-26	Apparat og fremgangsmåde til læsning af fødevarer
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
DK1748077T3 (da)	2013-04-08	Fremgangsmåde til fremstilling af protein
DK2081669T3 (da)	2019-01-02	Fremgangsmåde og anordning til fremstilling af granulater
DE602005002517D1 (de)	2007-10-31	Drehtisch
DK1941026T3 (da)	2014-07-21	Fremgangsmåder til fremstilling af protein under anvendelse af anti-senescensforbindelser
DK1725253T3 (da)	2014-07-07	Medikamenter og fremgangsmåder til behandling af hovedpine
DK2270818T3 (da)	2020-06-15	Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2079762T3 (da)	2013-01-07	Fremgangsmåde til fremstilling af hydroxypolymerestere og anvendelse deraf
DK2217376T3 (da)	2013-04-15	Kuvette og fremgangsmåde til anvendelse af denne kuvette
DK1954713T3 (da)	2013-02-11	Modificerede grønfluorescerende proteiner og fremgangsmåder til anvendelse af samme
DK2573166T3 (da)	2016-07-04	Fremgangsmåder til fremstilling af T-celler til celleterapi
DE602005015488D1 (de)	2009-08-27	Verbesserter verflüssigungsapparat
DK1739002T3 (da)	2014-01-20	Wakeboard-bindingsanordning og fremgangsmåde til fremstilling af anordningen
DK1864987T3 (da)	2010-04-12	Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater
NO20044012D0 (no)	2004-09-23	Fremgangsmate og et system
DK1743101T3 (da)	2009-09-07	Centrifugalpumpe og fremgangsm de til fremstilling af samme
NO20042477D0 (no)	2004-06-14	Fremgangsmate for chroma de-blokking
NO322006B2 (no)	2006-08-07	Anordning og fremgangsmåte for brønnintervenering